TCR Therapy Market is Segmented By Therapy Type (TCR-engineered T-cell Therapy, TCR-based Bispecific Antibody Therapy, TCR-based Soluble Receptor Therapy), By Target Indication (Nasopharyngeal Carcinoma, Multiple Myeloma, Head and Neck Carcinoma, Sarcoma, Melanoma, Acute Myeloid Leukemia, Lung Cancer, Ovarian Cancer, Merkel Cell Cancer, Others), By Target Antigen (NY-ESO-1, EBV, gp100, Others), By End-User (Hospitals and Cancer Centers , Academic and Research Institutes, Contract Manufacturing Organizations (CMOs), Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.